NeuroOne Medical Technologies Corporation Stock Other OTC
Equities
NMTC
US64130M1009
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2022 | 2.12 | Sales 2023 | 3.41 | Capitalization | 21.3M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -11M | EV / Sales 2022 | 7,761,717 x |
Net cash position 2022 | 10.94M | Net cash position 2023 | 5.14M | EV / Sales 2023 | 4,742,168 x |
P/E ratio 2022 |
-2.7
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 88.62% |
Latest transcript on NeuroOne Medical Technologies Corporation
Managers | Title | Age | Since |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 09-08-19 |
David Rosa
CEO | Chief Executive Officer | 59 | 17-07-19 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 17-08-03 |
Director/Board Member | 62 | 17-08-03 | |
Edward Andrle
BRD | Director/Board Member | 66 | 20-02-17 |
1st Jan change | Capi. | |
---|---|---|
-27.91% | 16.33B | |
-56.07% | 2.17B | |
+19.09% | 1.88B | |
-12.63% | 1.45B | |
+29.99% | 1.32B | |
+8.32% | 853M | |
-30.60% | 799M | |
-36.50% | 726M | |
+29.48% | 622M |